ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Status unconfirmed · Phase 2/Phase 3

Conditions studied: Prostate Cancer

In brief

The purposes of this study are to determine if DN-101 plus Taxotere lowers PSA levels, delays or limits disease progression and is safe with minimal side effects.

Key facts

Study ID
NCT00043576
Run by
Novacea
People needed
250
Starts
2002-08-01
Expected to finish
2005-12-01
Last updated by the study team
2009-03-12

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.